Paper
RSC Advances
7.89–7.76 (m, 4H, ArH), 7.39 (d, 2H, J ¼ 7.36 Hz, ArH), 7.22–7.16 NMR (100 MHz, DMSO-d6): d ¼ 159.2, 154.4, 152.0, 144.7, 140.5,
(m, 3H, ArH), 6.60 (s, 1H, ArH), 6.06 (s, 2H, OCH2), 5.31 (s, 2H, 135.5, 134.2, 132.6, 131.9, 123.2, 122.8, 121.8, 118.5, 115.0,
OCH2), 2.36 (s, 3H, CH3); 13C NMR (100 MHz, DMSO-d6): d ¼ 159.4, 101.9, 100.1, 98.2, 61.2; IR (nmax cmꢁ1, KBr): ¼ 3446, 3114, 2918,
154.6, 152.0, 144.4, 141.7, 138.4, 134.3, 132.0, 130.0, 123.4, 122.9, 1605, 1495, 1472, 1248; HRMS (ESI) [M + H]+ calcd for
122.8, 120.0, 115.2, 102.0, 100.2, 98.3, 61.3, 20.5; IR (nmax cmꢁ1
,
C
22H16BrN5O4: 494.0459, found: 494.0377.
6-((4-((1-(3,5-Dimethoxyphenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
KBr): ¼ 3412, 2918, 1603, 1507, 1474, 1251; HRMS (ESI) [M + H]+
calcd for C23H19N5O4: 430.1510, found: 430.1436.
phenyl)diazenyl)benzo[d][1,3]dioxol-5-ol (6i). Dark red solid,
6-((4-((1-(4-Fluorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)- M.p.: 167 ꢀC, 1H NMR (400 MHz, DMSO-d6) d ¼ 11.81 (s, 1H, OH),
diazenyl)benzo[d][1,3]dioxol-5-ol (6d). Dark red solid, M.p.: 207 8.63 (s, 1H, triazolyl-H), 7.89 (d, 2H, J ¼ 7.32 Hz, ArH), 7.24–7.09
ꢀC, 1H NMR (400 MHz, DMSO-d6) d ¼ 11.83 (s, 1H, OH), 8.95 (s, (m, 6H, ArH), 6.60 (s, 1H, ArH), 6.06 (s, 2H, OCH2), 5.31 (s, 2H,
1H, triazolyl-H), 7.95–7.88 (m, 4H, ArH), 7.45–7.16 (m, 5H, ArH), OCH2), 3.79 (s, 3H, OCH3), 3.76 (s, 3H, OCH3); 13C NMR (100
6.60 (s, 1H, ArH), 6.06 (s, 2H, OCH2), 5.32 (s, 2H, OCH2); 13C MHz, DMSO-d6): d ¼ 159.3, 154.4, 153.0, 152.0, 149.3, 145.3,
NMR (100 MHz, DMSO-d6): d ¼ 159.4, 154.5, 152.1, 144.8, 141.6, 144.7, 141.5, 132.0, 126.7, 125.6, 123.4, 115.6, 115.1, 114.1, 110.9,
132.9, 132.1, 123.4, 123.2, 122.5, 122.4, 116.8, 116.6, 115.3, 110.3, 101.8, 98.2, 61.1, 56.3, 55.7; IR (nmax cmꢁ1, KBr): ¼ 3422,
102.0, 100.3, 98.3, 61.3; IR (nmax cmꢁ1, KBr): ¼ 3420, 3084, 2917, 2926, 1601, 1508, 1474, 1226; HRMS (ESI) [M + H]+ calcd for
1601, 1514, 1475, 1238; HRMS (ESI) [M + H]+ calcd for C24H21N5O6: 476.1565, found: 476.1481.
C
22H16FN5O4: 434.1259, found: 434.1175.
Procedure for synthesis of amino triazole i.e. 4-((1-(4-
6-((4-((1-(Naphthalen-1-yl)-1H-1,2,3-triazol-4-yl)methoxy)- methoxyphenyl)-1H-1,2,3-triazol-4-yl)methoxy)aniline.
A
phenyl)diazenyl)benzo[d][1,3]dioxol-5-ol (6e). Dark red solid, mixture of 4-(prop-2-ynyloxy)aniline (1 mmol), 1-azido-4-
1
ꢀ
M.p.: 212 C, H NMR (400 MHz, DMSO-d6) d ¼ 11.82 (s, 1H, methoxybenzene (1 mmol), CuSO4$5H2O (10 mol%), sodium
OH), 8.82 (s, 1H, triazolyl-H), 8.20–8.11 (m, 2H, ArH), 7.92–7.90 ascorbate (20 mol%) and 10 mL of THF–water (60 : 40, v/v) was
(m, 2H, ArH), 7.74–7.61 (m, 4H, ArH), 7.45 (d, 2H, J ¼ 7.32 Hz, placed in a 50 mL round-bottomed ask. The reaction mixture
ArH), 7.27–7.17 (m, 3H, ArH), 6.61 (s, 1H, ArH), 6.07 (s, 2H, was stirred at 60 ꢀC for 2 h. The progress of reaction was
OCH2), 5.39 (s, 2H, OCH2); 13C NMR (100 MHz, DMSO-d6): d ¼ monitored by TLC using ethyl acetate–petroleum ether (70 : 30,
159.3, 154.5, 152.1, 144.8, 141.6, 133.5, 133.0, 132.0, 130.2, v/v) as eluent. Aer completion of the reaction as observed by
128.2, 127.9, 127.8, 127.4, 127.0, 125.3, 123.9, 123.4, 122.70, TLC, water (20 mL) was added to the reaction mixture. The
121.7, 115.3, 102.0, 100.2, 98.3, 61.2; IR (nmax cmꢁ1, KBr): ¼ precipitate formed was collected by ltration at pump and
3413, 3070, 2920, 1601, 1497, 1473, 1240; HRMS (ESI) [M + H]+ washed with water. The product so obtained, was recrystallized
calcd for C26H19N5O4: 466.1510, found: 466.1440.
from ethanol to afford amino triazole as brown solid in 87%
6-((4-((1-(4-Nitrophenyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)- yield.
diazenyl)benzo[d][1,3]dioxol-5-ol (6f). Dark red solid, M.p.:
Brown solid, M.p.: 120 ꢀC, 1H NMR (400 MHz, DMSO-d6) d ¼
239 ꢀC, 1H NMR (400 MHz, DMSO-d6) d ¼ 11.81 (s, 1H, OH), 9.19 8.50 (s, 1H, triazolyl-H), 7.93 (s, 1H, ArH), 7.38–7.08 (m, 6H,
(s, 1H, triazolyl-H), 8.45 (d, 2H, J ¼ 9.2 Hz, ArH), 8.24 (d, 2H, J ¼ ArH), 6.78 (s, 2H, NH2), 6.48 (s, 1H, ArH), 5.04 (s, 2H, OCH2),
7.36 Hz, ArH), 7.89 (d, 2H, J ¼ 9.16 Hz, ArH), 7.23–7.16 (m, 3H, 3.75 (s, 3H, OCH3); 13C NMR (100 MHz, DMSO-d6): d ¼ 162.0,
ArH), 6.60 (s, 1H, ArH), 6.07 (s, 2H, OCH2), 5.36 (s, 2H, OCH2); 153.3, 145.4, 126.6, 125.6, 125.3, 115.8, 113.9, 110.8, 61.5, 56.7,
13C NMR (100 MHz, DMSO-d6): d ¼ 159.2, 155.7, 154.6, 152.1, 55.8; IR (nmax cmꢁ1, lm): ¼ 3416, 3349, 2932, 1606, 1510; MS
146.7, 144.8, 141.7, 140.6, 132.2, 125.5, 123.5, 123.4, 120.7, (ESI) [M + H]+ calcd for C24H21N5O6: 297.14, found: 297.12.
115.3, 102.0, 100.2, 98.3, 61.3; IR (nmax cmꢁ1, KBr): ¼ 3422, 3082,
2925, 1597, 1505, 1481, 1341, 1238; HRMS (ESI) [M + H]+ calcd
for C22H16N6O6: 461.1204, found: 461.1105.
Acknowledgements
6-((4-((1-(3-Chloro-4-uorophenyl)-1H-1,2,3-triazol-4-yl)- HS and JS thank UGC, New Delhi, India for the grant of Jun-
methoxy)phenyl)diazenyl)benzo [d][1,3]dioxol-5-ol (6g). iorand Senior Research Fellowships.
Dark red solid, M.p.: 183 ꢀC, 1H NMR (400 MHz, DMSO-d6) d
¼ 11.47 (s, 1H, OH), 9.03 (s, 1H, triazolyl-H), 8.24 (d, 2H, J ¼
References
9.2 Hz, ArH), 7.99–7.88 (m, 3H, ArH), 7.71–7.66 (m, 1H,
ArH), 7.22–7.16 (m, 3H, ArH), 6.61 (s, 1H, ArH), 6.07 (s, 2H,
OCH2), 5.33 (s, 2H, OCH2); 13C NMR (100 MHz, DMSO-d6): d
¼ 159.4, 158.1, 154.6, 151.1, 144.8, 141.6, 133.5, 132.2,
123.4, 123.3, 122.0, 122.2, 122.4, 120.9, 118.1, 115.2, 101.9,
100.1, 98.3, 61.1; IR (nmax cmꢁ1, KBr): ¼ 3433, 3085, 2924,
1604, 1508, 1474, 1239; HRMS (ESI) [M + H]+ calcd for
1 I. M. Awad, A. A. Aly, R. A. Abdel and S. H. Ahmed, J. Inorg.
Biochem., 1998, 33, 77–89.
2 O. A. Phillips, E. E. Udo, M. E. Abdel-Hamid and R. Varghese,
Eur. J. Med. Chem., 2009, 44, 3217–3227.
3 S. A. Ibrahim, M. A. Gahami, Z. A. Khafagi and S. A. Gyar, J.
Inorg. Biochem., 1991, 43, 1–7.
C
22H15ClFN5O4: 468.0870, found: 468.0765.
6-((4-((1-(4-Bromophenyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-
4 A. A. Jarahpour, M. Motamedifar, K. Pakshir, N. Hadi and
Z. Zarei, Molecules, 2004, 9, 815–824.
diazenyl)benzo[d][1,3]dioxol-5-ol (6h). Dark red solid, M.p.: 212
ꢀC, 1H NMR (400 MHz, DMSO-d6) d ¼ 11.81 (s, 1H, OH), 9.00 (s,
1H, triazolyl-H), 7.87–7.78 (m, 7H, ArH), 7.21–7.15 (m, 2H, ArH),
6.60 (s, 1H, ArH), 6.06 (s, 2H, OCH2), 5.32 (s, 2H, OCH2); 13C
5 S. Samadhiya and H. Halve, Orient. J. Chem., 2001, 17, 119–
122.
6 G. R. Chatwal, Synthetic drugs, Himalaya Publishing House,
1996, p. 331.
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 5915–5926 | 5925